Martin Fan
Stock Analyst at Wedbush
(4.76)
# 620
Out of 5,044 analysts
65
Total ratings
45.8%
Success rate
50.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $24.16 | $10.63 | +127.26% | 2 | Oct 1, 2026 | |
| ZBIO Zenas BioPharma | Reiterated: Buy | $45 | $27.26 | +65.08% | 5 | Sep 30, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $165 | $82.11 | +100.95% | 6 | Sep 24, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Hold | $80 → $50 | $41.17 | +21.45% | 5 | Sep 23, 2026 | |
| IMUX Immunic | Reiterated: Buy | $45 | $8.19 | +449.45% | 2 | Sep 10, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | $60 → $70 | $31.85 | +119.78% | 4 | Sep 3, 2026 | |
| RNAC Cartesian Therapeutics | Reiterated: Buy | $38 | $7.06 | +438.63% | 7 | Aug 18, 2026 | |
| VOR Vor Biopharma | Reiterated: Hold | $18 → $27 | $19.90 | +35.68% | 4 | Aug 12, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $15 → $22 | $4.00 | +450.00% | 4 | Aug 12, 2026 | |
| SANA Sana Biotechnology | Reiterated: Buy | $7 | $2.79 | +150.90% | 5 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 | $4.24 | -52.83% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $6.94 | +476.37% | 3 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.18 | +221.10% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.83 | +161.10% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $50.80 | -9.45% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $45 | $45.95 | n/a | 2 | Aug 7, 2025 |
Eupraxia Pharmaceuticals Inc.
Oct 1, 2026
Reiterated: Buy
Price Target: $24.16
Current: $10.63
Upside: +127.26%
Zenas BioPharma
Sep 30, 2026
Reiterated: Buy
Price Target: $45
Current: $27.26
Upside: +65.08%
Oruka Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: $165
Current: $82.11
Upside: +100.95%
Nektar Therapeutics
Sep 23, 2026
Reiterated: Hold
Price Target: $80 → $50
Current: $41.17
Upside: +21.45%
Immunic
Sep 10, 2026
Reiterated: Buy
Price Target: $45
Current: $8.19
Upside: +449.45%
First Tracks Biotherapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $60 → $70
Current: $31.85
Upside: +119.78%
Cartesian Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $38
Current: $7.06
Upside: +438.63%
Vor Biopharma
Aug 12, 2026
Reiterated: Hold
Price Target: $18 → $27
Current: $19.90
Upside: +35.68%
Zura Bio
Aug 12, 2026
Reiterated: Buy
Price Target: $15 → $22
Current: $4.00
Upside: +450.00%
Sana Biotechnology
Aug 11, 2026
Reiterated: Buy
Price Target: $7
Current: $2.79
Upside: +150.90%
Aug 6, 2026
Reiterated: Sell
Price Target: $2
Current: $4.24
Upside: -52.83%
May 21, 2026
Reiterated: Buy
Price Target: $40
Current: $6.94
Upside: +476.37%
May 14, 2026
Reiterated: Buy
Price Target: $7
Current: $2.18
Upside: +221.10%
May 8, 2026
Reiterated: Buy
Price Target: $10
Current: $3.83
Upside: +161.10%
Feb 26, 2026
Reiterated: Buy
Price Target: $46
Current: $50.80
Upside: -9.45%
Aug 7, 2025
Reiterated: Buy
Price Target: $40 → $45
Current: $45.95
Upside: n/a